Taste bud stem cells could be key to diabetes cure
NCT ID NCT03366168
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 12 times
Summary
This study explores whether stem cells from taste buds can be turned into insulin-making cells. Researchers will take tiny tissue samples from the tongues of 250 healthy adults to isolate and grow these stem cells in a lab. The goal is to see if this is possible in humans, which could one day lead to new diabetes treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- taste bud stem cells
- What this could lead to
- If successful, this could point toward a new way to create insulin-producing cells for diabetes treatment.
- What could go wrong
- This is a very early pilot study in healthy volunteers, not people with diabetes. It only aims to see if stem cells can be isolated and grown in a lab; it may not lead to a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institute of Aging, Clinical Research Unit
RECRUITINGBaltimore, Maryland, 21224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could diabetes be silently damaging your hearing?
- Press play on better health: could recording doctor visits boost Self-Care in seniors?
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- A simple card game could transform diabetes care
- Can a new injection help tackle obesity and diabetes? a safety trial begins